Article Information
PubMed
Published By
Print ISSN
Online ISSN
History
- Received April 28, 2011
- Accepted September 19, 2011
- Published online December 9, 2011.
Copyright & Usage
Copyright © 2011 by the American Society of Nephrology
Author Information
- Correspondence:
Dr. Jan van den Brand, Radboud University Nijmegen Medical Centre, Department of Nephrology, 464, PO Box 9101, 6500 HB Nijmegen, The Netherlands. Phone: +31 24 3668025; Fax: +31 24 3540022; E-mail: a.vandenbrand{at}nier.umcn.nl
Statistics from Altmetric.com
Article usage
Cited By...
In this issue
Low-Molecular-Weight Proteins as Prognostic Markers in Idiopathic Membranous Nephropathy
Jump to section
More in this TOC Section
Original Articles
Epidemiology and Outcomes
Cited By...
- Safety of Rituximab Compared with Steroids and Cyclophosphamide for Idiopathic Membranous Nephropathy
- Association of Anti-PLA2R Antibodies with Outcomes after Immunosuppressive Therapy in Idiopathic Membranous Nephropathy
- Long-Term Outcomes in Idiopathic Membranous Nephropathy Using a Restrictive Treatment Strategy
- Antiphospholipase A2 Receptor Antibody Titer and Subclass in Idiopathic Membranous Nephropathy
- Is Long-Term Prediction in Membranous Nephropathy (MGN) Better Than the Weatherman's Forecast Capacity?
- Prognostic Value of Risk Score and Urinary Markers in Idiopathic Membranous Nephropathy